Bare Financial Services
RAPP icon

Bare Financial Services’s Rapport Therapeutics RAPP Stock Holding History

Bare Financial Services’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.31K Hold
39
– – ﹤0.01% 1364
2026
Q2 		$1.62K Buy
+39
New +$1.43K ﹤0.01% 1192
2026
Q1 		– Sell
-16
Closed -$485 – 1905
2025
Q4 		$485 Buy
+16
New +$443 ﹤0.01% 1431

Other funds holding RAPP

Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return

Bare Financial Services's RAPP Position: Q3 2026 in Review

Bare Financial Services held its Rapport Therapeutics (RAPP) position steady in Q3 2026 at 39 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1364.

Bare Financial Services first reported a position in RAPP in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.62K in Q2 2026. 54 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

  • Bare Financial Services held 39 shares of Rapport Therapeutics worth $1.31K as of Q3 2026.
  • Bare Financial Services left its Rapport Therapeutics share count unchanged in Q3 2026.
  • Rapport Therapeutics made up ﹤0.01% of Bare Financial Services's portfolio in Q3 2026, its #1364 holding.
  • Bare Financial Services first reported a position in Rapport Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Bare Financial Services's Rapport Therapeutics position peaked at $1.62K in Q2 2026.
  • 54 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on Bare Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.